These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 2124212

  • 21. In-vitro activity of fleroxacin compared with three other quinolones.
    Bremner DA, Dickie AS, Singh KP.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():19-23. PubMed ID: 3144536
    [Abstract] [Full Text] [Related]

  • 22. Urinary bactericidal activity and pharmacokinetics of enoxacin versus norfloxacin and ciprofloxacin in healthy volunteers after a single oral dose.
    Well M, Naber KG, Kinzig-Schippers M, Sörgel F.
    Int J Antimicrob Agents; 1998 Apr; 10(1):31-8. PubMed ID: 9624541
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
    Hummler H, Richter WF, Hendrickx AG.
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):34-45. PubMed ID: 8397453
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Pharmacokinetics and dose adaptation of ofloxacine, pefloxacine and ciprofloxacine during haemodialysis and continuous ambulatory peritoneal dialysis].
    Daniel JP, Moulin B, Christmann D.
    Ann Pharm Fr; 2004 May; 62(3):177-85. PubMed ID: 15243351
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Quinolone pharmacokinetics.
    Robson RA.
    Int J Antimicrob Agents; 1992 Dec; 2(1):3-10. PubMed ID: 18611512
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
    Fukuda H, Kawamura Y.
    Jpn J Antibiot; 2002 Jun; 55(3):270-80. PubMed ID: 12199111
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics of pefloxacin in goats after intravenous or oral administration.
    Malik JK, Rao GS, Ramesh S, Muruganandan S, Tripathi HC, Shukla DC.
    Vet Res Commun; 2002 Feb; 26(2):141-9. PubMed ID: 11922483
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics and body fluid penetration of fleroxacin in healthy volunteers.
    Sorgel F, Metz R, Naber K, Seelmann R, Muth P.
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():155-67. PubMed ID: 3144534
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.
    Stuck AE, Frey FJ, Heizmann P, Brandt R, Weidekamm E.
    Antimicrob Agents Chemother; 1989 Mar; 33(3):373-81. PubMed ID: 2499248
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.